RAC
Click for more information
1.11% $1.83 race oncology ltd

Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene, page-99

  1. ma420
    6,633 Posts.
    lightbulb Created with Sketch. 1670
    clock Created with Sketch.
    14/06/24
    00:39
    Post #: 74307289
    Thanks.

    3. I didn’t mean that FDA ODD is the same as marketing it under ODD. My point is simply any other AML drug could still pip us to the post given the huge number of AML trials.

    4. BTD, Fast track approval etc., will SHs be informed of applications made?

    IND is planned to be opened in CY25. Why not open one now for AML?
    RAC Price at posting: $1.87 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83 		Change
0.020(1.11%) 		Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.